Cargando…
PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma
BACKGROUND: Endometrial carcinoma represents one of the most common cancer types of the female reproductive tract. If diagnosed at an early stage, the 5-year survival rate is promising. However, recurrence and chemoresistance remain problematic for at least 15% of the patients. In the present study,...
Autores principales: | Zhou, Jing-Wei, Tang, Juan-Juan, Sun, Wei, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441178/ https://www.ncbi.nlm.nih.gov/pubmed/30925862 http://dx.doi.org/10.1186/s10020-019-0079-0 |
Ejemplares similares
-
PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells
por: Tang, Wei, et al.
Publicado: (2022) -
Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma
por: Wang, Lin, et al.
Publicado: (2014) -
An Unusual Solitary Metatarsal Metastasis from an Endometrioid Endometrial Adenocarcinoma
por: Longo, Raffaele, et al.
Publicado: (2015) -
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells
por: Ewers, Katharina M., et al.
Publicado: (2021) -
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
por: Schmidt, Linnéa, et al.
Publicado: (2022)